According to Fresenius Medical Care's latest financial reports the company has $1.70 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $1.70 B | 11.26% |
2022-12-31 | $1.53 B | -16.5% |
2021-12-31 | $1.83 B | 19.83% |
2020-12-31 | $1.52 B | 19.63% |
2019-12-31 | $1.27 B | -50.23% |
2018-12-31 | $2.56 B | 118.74% |
2017-12-31 | $1.17 B | 16.24% |
2016-12-31 | $1.01 B | 22.97% |
2015-12-31 | $0.82 B | 2.43% |
2014-12-31 | $0.80 B | 12.64% |
2013-12-31 | $0.71 B | 3.47% |
2012-12-31 | $0.68 B | 50.5% |
2011-12-31 | $0.45 B | -12.56% |
2010-12-31 | $0.52 B | 73.61% |
2009-12-31 | $0.30 B | 35.36% |
2008-12-31 | $0.22 B | -9.19% |
2007-12-31 | $0.24 B | 53.86% |
2006-12-31 | $0.15 B | 87.63% |
2005-12-31 | $84.88 M | 43.86% |
2004-12-31 | $59 M | 21.88% |
2003-12-31 | $48.41 M | -27.18% |
2002-12-31 | $66.47 M | -10.77% |
2001-12-31 | $74.5 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Amgen AMGN | $10.94 B | 542.88% | ๐บ๐ธ USA |
Baxter BAX | $3.02 B | 77.75% | ๐บ๐ธ USA |
DaVita DVA | $0.35 B | -79.10% | ๐บ๐ธ USA |
IDEXX Laboratories IDXX | $0.39 B | -76.65% | ๐บ๐ธ USA |
Quest Diagnostics
DGX | $0.47 B | -72.16% | ๐บ๐ธ USA |
Teleflex TFX | $0.22 B | -86.91% | ๐บ๐ธ USA |
LabCorp LH | $99.3 M | -94.17% | ๐บ๐ธ USA |
Rockwell Medical
RMTI | $10.93 M | -99.36% | ๐บ๐ธ USA |